Trial intelligence / Profile preview

QL Block vs Local Infiltration for Pain After Laparoscopic Hysterectomy

NCT06709716Phase 4Not yet recruiting

Sponsor
Walter Reed National Military Medical Center
Start
Dec 2024
Primary completion
Dec 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of liposomal bupivacaine in postoperative pain, sponsored by Walter Reed National Military Medical Center. Planned start Dec 2024; status: not yet recruiting.

02

Drugs

liposomal bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT06709716.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06709716.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call